Evidence map›Paper›PMID 38832170›Full record

ArticleCureus2024

Bombay Blood Group: A Report of Two Cases.

Asma Nasir, Aiman Minhas, Ayisha Imran, Omar Chughtai, Akhtar S Chughtai

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Asma NasirDepartment of Haematology and Blood Bank, Chughtai Institute of Pathology, Lahore, PAK.
Aiman MinhasDepartment of Haematology and Blood Bank, Chughtai Institute of Pathology, Lahore, PAK.
Ayisha ImranDepartment of Haematology and Blood Bank, Chughtai Institute of Pathology, Lahore, PAK.
Omar ChughtaiDepartment of Pathology and Laboratory Medicine, Chughtai Institute of Pathology, Lahore, PAK.
Akhtar S ChughtaiDepartment of Pathology and Laboratory Medicine, Chughtai Institute of Pathology, Lahore, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Timely detection of rare blood groups can be lifesaving, as individuals with these groups can only receive blood products from donors within the same group. The Bombay blood group is characterized by the absence of A, B, and H antigens on the surface of RBCs and can be easily missed in routine blood grouping if only forward grouping is performed. In reverse grouping, it is necessary to test the patient's serum with pooled O cells to differentiate between the O and Bombay blood groups. Further workup is conducted by testing the patient's red cells with anti-H lectin (antisera), where the absence of an agglutination reaction suggests the Bombay phenotype. In blood group O testing, the patient's blood serum mixed with pooled O cells yields no agglutination reaction in reverse typing, whereas testing RBCs with anti-H lectin results in a strong agglutination reaction, as H-antigen is present at its highest concentration in these individuals. Correct diagnosis of such rare blood types can save patients' lives as well as prevent the consequences of a wrong blood transfusion. Here we present two cases that were diagnosed as having the Bombay phenotype on blood group testing in our blood bank. Both were initially misdiagnosed as blood group O by an outside laboratory. Correct diagnosis of rare blood groups in blood banks is imperative, as a misdiagnosis can result in fatal outcomes.

Indexed as

anti-h lectinbombay blood grouph-antigenpooled 'o' cellsrare blood group

Identifiers

PMID38832170
PMCPMC11145363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.